Osteopro 30 pcs
OsteoproOSTEOPRO mineral complex is recommended to supplement calcium deficiency in the body, in osteoporosis and to accelerate bone fusion in fractures. The mineral part is represented by calcium, phosphorus and other elements that promote the full absorption of calcium from the gastrointestinal tract and improve its fixation in the bones. The organic component includes proteins that enhance the osteogenic effect.
Indications for use (instruction): Osteopro 30 pcs
OSTEOPRO® is an additional source of calcium, phosphorus and proteins (collagen, growth factors, osteocalcin). Recommended to regulate calcium-phosphorus metabolism in case of calcium deficiency in the body, osteoporosis and to improve bone growth in fractures.
How to use
In case of fractures: from the first day of the fracture and for 14 days, it is recommended to take 1 tablet per day with a small amount of drinking water, preferably during meals. From the 15th day, it is recommended to switch to taking 2 tablets per day (in 2 divided doses) with a small amount of drinking water, preferably during meals. The tablets can be chewed to make swallowing easier. On the recommendation of a doctor, the recommended daily dose may be increased. The course of application is determined individually. The minimum recommended course of application is 1 month. It is recommended to consult a doctor before use.
In other conditions, in order to regulate calcium-phosphorus metabolism, with a calcium deficiency in the body, osteoporosis: take for adults 2-4 tablets per day (in 2 divided doses) with a small amount of drinking water, preferably during meals. The tablets can be chewed to make swallowing easier. On the recommendation of a doctor, the recommended daily dose may be increased. The course of application is determined individually. The minimum recommended course of application is 1 month. It is recommended to consult a doctor before use.
Contraindications
Individual intolerance to the components, hypercalcemia, hypercalciuria, urolithiasis disease, tissue calcification, severe renal dysfunction, hyperproliferative processes.
Composition
1 tablet contains: active ingredient: microcrystalline hydroxyapatite complex MCNAatm (MCN-Saltm) - 1000 mg (mg) Excipients: fillers: microcrystalline cellulose, sodium carboxymethyl cellulose, hydroxypropyl cellulose; anti-caking agents: magnesium stearate, amorphous silicon dioxide.
MCHAtm (MCH-Caltm) - contains 250 mg (mg) of proteins (type I collagen and non-collagen peptides, including insulin-like growth factor I and type II (IGF1 - 0.285 μg (μg), IGF2 - 0.17 μg (μg) ), transforming growth factor beta (TGF-β - 0.0275 μg (μg)), osteocalcin - 604 μg (μg)) and 670 mg (mg) calcium hydroxyapatite (including 250 mg (mg) calcium, 125 mg ( mg) phosphorus, 4 mg (mg) magnesium, 64 μg (μg) zinc, 3.9 μg (μg) iron, and 1.4 μg (μg) boron).
** typical average content of components.
Without GMO.
Release form
Tablets weighing 1.5 g ± 7.5%, 10, 14, 30 or 60 tablets in a jar packed in a cardboard box.
Manufacturer
Dr. Gustav Klein GmbH & Co. KG, Германии.
Sanitary and hygienic conclusion
№43 dated 31.07.2020
This product is not a drug.